Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 99
Filter
2.
Neuro Endocrinol Lett ; 40(2): 79-84, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31785214

ABSTRACT

BACKGROUND: The aim of the study was to determine clinical manifestations and outcome of Listeria monocytogenes meningitis (LM) and to compare with other forms of bacterial meningitis (BM). MATERIAL AND METHODS: We analyzed records of all adult patients with BM who were hospitalized between January 2010 and December 2017 in the largest neuroinfection center in Poland. RESULTS: Out of 343 analyzed patients with BM 24 were diagnosed to have LM. Patients with LM were older compared to patients with other forms of BM (62 years vs. 57 years, p=0.039), were more likely to have cancer (16.7% vs. 4.7%, p=0.045), receive immunosuppressive treatment (45.8% vs. 10.7%, p<0.001), or be immunocompromised in any way (62.5% vs. 35.5%, p=0.016). Blood tests showed lower WBC (10.7 × 103 cells/µl vs. 15.5 × 103 cells/µl, p=0.004), C-reactive protein (150 mg/L vs. 221 mg/L, p=0,019) and procalcitonin (1.27 ng/mL vs. 3.78 ng/mL, p=0.003) in LM group. Analysis of cerebrospinal fluid showed lower cell count (531.5 cells/µL vs. 1100 cells/µL, p<0.001) and lower chloride (113 mmol/L vs. 117 mmol/L, p=0.036) in patients with LM. In the multiple logistic regression analysis, immunosuppressive therapy was the only variable independently associated with LM (OR:8.72, CI 95%:1.41-64.34, p=0.024). CONCLUSIONS: LM is associated with older age, cancer and immunosuppressive therapy. However, in multivariate analysis only immunosuppressive therapy turned out to be an independent risk factor for LM.


Subject(s)
Listeria monocytogenes/physiology , Meningitis, Listeria/diagnosis , Meningitis, Listeria/pathology , Adult , Aged , Disease Progression , Female , Humans , Immunocompromised Host/physiology , Immunosuppressive Agents/therapeutic use , Listeria monocytogenes/isolation & purification , Male , Meningitis, Listeria/epidemiology , Meningitis, Listeria/etiology , Middle Aged , Neoplasms/complications , Neoplasms/epidemiology , Neoplasms/microbiology , Poland/epidemiology , Prognosis , Retrospective Studies , Risk Factors
4.
Intern Med ; 56(19): 2655-2659, 2017 Oct 01.
Article in English | MEDLINE | ID: mdl-28883240

ABSTRACT

An 80-year-old man, who had been diagnosed with ulcerative colitis, was admitted due to a fever and bloody diarrhea and was treated with a glucocorticoid and azathioprine. After 5 days, he developed an impaired consciousness, headache, and neck stiffness. A sample of the colonic mucosa, blood cultures, and cerebrospinal fluid revealed Listeria monocytogenes infection. Intravenous ampicillin improved the symptoms of fever, bloody diarrhea, and headache without any neurological sequelae. Physicians should consider that Listeria enteritis complicating ulcerative colitis can cause septicemia and meningitis in immunosuppressed patients. A patient's central nervous system can avoid the effects of Listeria meningitis by an early diagnosis and appropriate treatment.


Subject(s)
Ampicillin/therapeutic use , Colitis, Ulcerative/complications , Colitis, Ulcerative/drug therapy , Listeria monocytogenes/drug effects , Meningitis, Listeria/drug therapy , Meningitis, Listeria/etiology , Sepsis/drug therapy , Aged, 80 and over , Humans , Male , Sepsis/diagnosis , Treatment Outcome
5.
Rev Chilena Infectol ; 32(4): 464-6, 2015 Aug.
Article in Spanish | MEDLINE | ID: mdl-26436795

ABSTRACT

Listeria meningoencephalitis is a rare condition, occurring mainly in immunocompromised patients. We present two cases of Listeria monocytogenes meningoencephalitis in immunocompetent children, with successful treatment with betalactam/aminoglycoside combination. Unpasteurized cheese was postulated as the source of infection.


Subject(s)
Cheese/poisoning , Foodborne Diseases/microbiology , Immunocompetence , Meningitis, Listeria/etiology , Pasteurization , Aminoglycosides/therapeutic use , Cheese/microbiology , Child, Preschool , Female , Humans , Infant , Meningitis, Listeria/drug therapy , beta-Lactamase Inhibitors/therapeutic use , beta-Lactams/therapeutic use
6.
Rev. chil. infectol ; 32(4): 464-466, ago. 2015.
Article in Spanish | LILACS | ID: lil-762646

ABSTRACT

Listeria meningoencephalitis is a rare condition, occurring mainly in immunocompromised patients. We present two cases of Listeria monocytogenes meningoencephalitis in immunocompetent children, with successful treatment with betalactam/aminoglycoside combination. Unpasteurized cheese was postulated as the source of infection.


La meningoencefalitis por Listeria spp. es una infección infrecuente, principalmente en pacientes con algún tipo de inmunosupresión. Presentamos dos casos clínicos de meningitis por Listeria monocytogenes en niñas inmunocompetentes con tratamiento exitoso con β lactámicos combinados con aminoglucósidos; se identificó la ingesta de queso no pasteurizado como probable fuente de infección.


Subject(s)
Child, Preschool , Female , Humans , Infant , Cheese/poisoning , Foodborne Diseases/microbiology , Immunocompetence , Meningitis, Listeria/etiology , Pasteurization , Aminoglycosides/therapeutic use , Cheese/microbiology , Meningitis, Listeria/drug therapy , beta-Lactamase Inhibitors/therapeutic use , beta-Lactams/therapeutic use
7.
Int J Mol Sci ; 16(7): 14669-76, 2015 Jun 29.
Article in English | MEDLINE | ID: mdl-26132570

ABSTRACT

Alemtuzumab, a humanized monoclonal antibody targeting the surface molecule CD52, leads to a rapid depletion of immune cells in the innate and adaptive immune system. In phase 2 and 3 trials in multiple sclerosis (MS), infections have been reported more frequently in alemtuzumab than in interferon beta treated patients. Here we report two patients treated with alemtuzumab for MS developing Listeria meningitis few days after the first infusion cycle. Both patients recovered completely after prompt diagnosis and adequate treatment. Physicians and patients should be aware of this serious, but treatable complication.


Subject(s)
Antibodies, Monoclonal, Humanized/adverse effects , Meningitis, Listeria/etiology , Multiple Sclerosis/drug therapy , Opportunistic Infections/etiology , Adult , Alemtuzumab , Antibodies, Monoclonal, Humanized/therapeutic use , Female , Humans , Middle Aged , Multiple Sclerosis/complications
8.
New Microbiol ; 38(1): 113-8, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25742155

ABSTRACT

This report describes a case of meningitis caused by Listeria monocytogenes in a stem cell transplant recipient on immunosuppressive therapy for cutaneous chronic graft-versus host disease. A 59-year-old woman had undergone allogeneic stem cell transplantation (from a matched unrelated donor) 13 months previously for chronic lymphocytic leukemia. She was on regular hematologic follow-up. Though her previous malignancy has been in remission, she was immunosuppressed due to the pharmacological treatment. We describe a meningitis caused by a typical food-borne pathogen, dangerous in patients with impaired cell-mediated immunity. Moreover the bacterium had a multidrug resistance, a rare characteristic in clinical listeriosis. Rapid diagnosis and treatment are key factors in these cases. We chose ampicillin and rifampicin that allowed a complete resolution of the clinical manifestations.


Subject(s)
Hematopoietic Stem Cell Transplantation/adverse effects , Listeria monocytogenes/isolation & purification , Meningitis, Listeria/microbiology , Anti-Bacterial Agents/therapeutic use , Female , Humans , Immunocompromised Host , Listeria monocytogenes/genetics , Meningitis, Listeria/drug therapy , Meningitis, Listeria/etiology , Meningitis, Listeria/immunology , Middle Aged , Transplantation, Homologous/adverse effects
10.
Reumatol Clin ; 9(6): 340-7, 2013.
Article in English, Spanish | MEDLINE | ID: mdl-24094430

ABSTRACT

INTRODUCTION: Infections in patients with systemic lupus erythematosus cause significant morbidity. Infection due to Listeria monocytogenes (LM) is considered an opportunistic disease, and has been published on rare occasions in patients with SLE. OBJECTIVE: To review the presentation of listeria infections in the central nervous system (CNS) in SLE patients. METHODOLOGY: We conducted a literature review, selecting cases with central nervous system infection and confirmation of LM infection through culture. RESULTS: Twenty six cases are described. The most common presentation was meningitis, with meningoencephalitis and brain abscesses being less frequent. The predisposing factors are: use of glucocorticoids, immunosuppressants, renal replacement therapy and the activity flares. CONCLUSION: CNS infection by listeria is rare and sometimes fatal. The atypical presentation may lead to a delay in diagnosis and appropriate treatment. L. monocytogenes should be included in the differential diagnosis of patients with SLE with neurological manifestations.


Subject(s)
Brain Abscess/etiology , Listeriosis/etiology , Lupus Erythematosus, Systemic/complications , Meningitis, Listeria/etiology , Adolescent , Adult , Female , Humans , Male , Middle Aged , Young Adult
11.
Breast Cancer Res Treat ; 127(3): 841-4, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21369716

ABSTRACT

Trastuzumab, a monoclonal antibody against the HER2 receptor, is a major breakthrough in the treatment of HER2+ breast cancer. However, its high molecular weight precludes it from crossing the intact blood-brain barrier, making the central nervous system a sanctuary to HER2+ breast cancer metastases. We prospectively assessed functional outcome and toxicity of administering trastuzumab directly into the cerebrospinal fluid of a patient with leptomeningeal carcinomatosis (LC) and brain metastases from HER2+ breast cancer that had already been treated with other intrathecal chemotherapy, with no benefit. Upon signed informed consent, weekly lumbar puncture with administration of trastuzumab 25 mg was begun to a 44 year-old women with metastatic breast cancer (lymph node, bone, lung, and liver involvement) previously treated with tamoxifen, letrozole, anthracyclines, taxanes, capecitabine, intravenous trastuzumab, and lapatinib. She received 67 weekly administrations of intrathecal trastuzumab with marked clinical improvement and no adverse events. She survived 27 months after LC diagnosis. A complete leptomeningeal response, with no evidence of leptomeningeal metastasis at necropsy, was achieved. We believe that intrathecal trastuzumab administration should be prospectively evaluated to confirm clinical activity and optimize dose, schedule, and duration of treatment.


Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Antineoplastic Agents/therapeutic use , Breast Neoplasms/drug therapy , Meningeal Carcinomatosis/drug therapy , Receptor, ErbB-2/genetics , Adult , Antibodies, Monoclonal, Humanized/administration & dosage , Antineoplastic Agents/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Female , Humans , Meningeal Carcinomatosis/genetics , Meningeal Carcinomatosis/secondary , Meningitis, Listeria/etiology , Trastuzumab
12.
BMJ Case Rep ; 20112011 May 12.
Article in English | MEDLINE | ID: mdl-22696737

ABSTRACT

The authors report on a case of Listeria rhomboencepahlitis in a previously undiagnosed HIV positive man. This case is of interest as the incidence of Listeria has increased dramatically in recent years and so may increase in the HIV-infected population. The organism is inherently resistant to cephalosporin antibiotics, empirically employed in the treatment of central nervous system infections and thus highlights the need to include amoxicillin in meningitis treatment regimes in patients at risk of HIV infection as well as the older and those known to be immuno-compromised.


Subject(s)
Amoxicillin/therapeutic use , Anti-Bacterial Agents/therapeutic use , HIV Infections/complications , Meningitis, Listeria/etiology , Adult , Amoxicillin/administration & dosage , Anti-Bacterial Agents/administration & dosage , Humans , Male , Meningitis, Listeria/diagnosis , Meningitis, Listeria/drug therapy
13.
Rheumatol Int ; 31(4): 555-7, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20668857

ABSTRACT

Listeria meningitis, a rare but life-threatening infection in patients with systemic lupus erythematosus, often represents a diagnostic and therapeutic challenge because of its rarity and non-representative manifestations. L. monocytogenes is an intracellular pathogen capable of spreading directly from cell to cell without exposure to the extracellular humoral immune system. With the evolving trend of intense immunosuppressive therapy, patients with SLE usually have abnormal cell-mediated immunity and are susceptible to L. monocytogenes infections. The gastrointestinal tract is usually the portal of entry, and a transient gastroenteritis may precede the full-blown meningitides. Ampicillin and penicillin G are the drugs of choice. For patients who are allergic to penicillin, trimethoprim-sulfamethoxazole is an eligible alternative. Delay in diagnosis and inappropriate antibiotics are detrimental to the outcome. Herein, we report a young woman with systemic lupus erythematosus who developed listeria meningitis. Clinicians are advised to be aware of the clinical presentations of this disease.


Subject(s)
Lupus Erythematosus, Systemic/complications , Meningitis, Listeria/etiology , Adult , Female , Humans , Meningitis, Listeria/drug therapy
15.
Rev. chil. neuro-psiquiatr ; 46(4): 270-279, dic. 2008. ilus, tab
Article in Spanish | LILACS | ID: lil-547789

ABSTRACT

Listeria Monocytogenes is a gram-positive Bacillus that affects immunocompromised patients, newborn, pregnant women and persons over 65 years. Infection is acquired through contaminated food. The Bacillus has predilection for the central nervous system. Its presents most commonly as an acute meningitis, it also presents as a chronic meningitis, cerebritis, rhomboencephalitis, brain and spinal abscess. Diagnosis for L. monocytogenes is made through positive cultures in blood and cerebrospinal fluid (CSF). Magnetic Resonance (MR) also helps to in the diagnosis of neurolisteriosis lesions. We described seven cases with L. Monocytogenes infection during 2007 and 2008, with four cases over the aged of 65 years old. Five presented acute meningitis; two rhomboencephalitis and one patient had meningoencephalitis. Six cases showed inflammatory CSF with pleocytosis with polymorphonuclear prevail and normal glycorrachia. MR showed inflammatory findings in five patients and focal brainstem lesions in two cases, one had acute hydrocephalus due arachnoiditis. Five patients improve clinically and two fatal cases were described. Listeriosis is the third cause of meningitis and should be consider in the differential diagnosis of meningitis with clear fluid, especially with pleocytosis and normal glycorrachia. Other clues of the diagnosis are dizziness with or without nystagmus and brainstem compromise. Arachnoiditis should be avoided with steroidal use. The diagnostic imaging test of choice for brain stem compromise is MR.


La Listeria Monocytogenes es un bacilo Gram-positivo que afecta a pacientes inmunocomprometidos, a niños, embarazadas y personas mayores de 65 años. El modo de adquirirla es la ingestión de alimentos contaminados. El bacilo tiene predilección por el sistema nervioso central, donde su expresión más frecuente es la meningitis aguda, también puede presentarse como meningitis crónica, cerebritis, rombencefalitis, abscesos cerebrales y espinales. El cultivos positivos de L. monocytogenes en muestras de sangre o líquido cefalorraquídeo, permite confirmar el diagnóstico. La Resonancia Magnética de cerebro también contribuye al diagnóstico de las lesiones por neurolisteriosis. Se analizan siete casos de neurolisteriosis ocurridos los a±os 2007 y 2008, entre ellos cuatro pacientes mayores de 65 años. La meningitis aguda fue la forma de presentación en cinco de ellos, dos evolucionaron como rombencefalitis y uno como meningoencefalitis. El LCR fue inflamatorio en seis de los pacientes, con pleocitosis depredominio polinuclear, pero glucorraquia normal. La RM mostró imágenes de aspecto inflamatorio en cinco de los enfermos, dos de ellos tenían lesiones focales del tronco cerebral, uno hizo un hidrocéfalo agudo por aracnoiditis. Cinco pacientes presentaron una evolución clínica favorable y dos fallecieron. Siendo la listeriosis la tercera causa etiológica de meningitis, debe ser considerada en el diagnóstico diferencial de meningitis a líquido claro, especialmente en LCR con abundantes polinucleares y glucosa en rangos normales. Otras claves son la sensación vertiginosa con o sin nistagmus y el compromiso de nervios craneales de origen protuberancial. Debe prevenirse las aracnoiditis con el uso precoz de corticoides. Es obligatorio el estudio con RM en toda sospecha de neurolisteriosis.


Subject(s)
Humans , Male , Adolescent , Female , Middle Aged , Meningitis, Listeria/diagnosis , Meningitis, Listeria/etiology , Meningitis, Listeria/drug therapy , Acute Disease , Anti-Bacterial Agents/therapeutic use , Clinical Evolution , Cerebrospinal Fluid/microbiology
19.
World J Gastroenterol ; 13(32): 4391-3, 2007 Aug 28.
Article in English | MEDLINE | ID: mdl-17708617

ABSTRACT

Listeria monocytogene is a well-recognized cause of bacteremia in immunocompromised individuals, including solid organ transplant recipients, but has been rarely reported following orthotopic liver transplantation. We describe a case of listeria meningitis that occurred within a week after liver transplantation. The patient developed a severe headache that mimicked tacrolimus encephalopathy, and was subsequently diagnosed with listeria meningitis by cerebrospinal fluid culture. The infection was successfully treated with three-week course of intravenous ampicillin. Recurrent hepatitis C followed and was successfully treated with interferon alfa and ribavirin. Fourteen cases of listeriosis after orthotopic liver transplantation have been reported in the English literature. Most reported cases were successfully treated with intravenous ampicillin. There were four cases of listeria meningitis, and the mortality of them was 50%. Early detection and treatment of listeria meningitis are the key to obtaining a better prognosis.


Subject(s)
Listeria monocytogenes , Liver Transplantation/adverse effects , Meningitis, Listeria/diagnosis , Meningitis, Listeria/etiology , Ampicillin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Central Nervous System/microbiology , Humans , Male , Meningitis, Listeria/drug therapy , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...